NCMAG121 Nivolumab in combination with ipilimumab advice document: April 2025
Posted on:
Document Type
NCMAG advice
Process guidance
Summary
Nivolumab in combination with ipilimumab for the neoadjuvant treatment of resectable stage III melanoma. Off-label use.
Decision: Supported